ArticleApplied microbiology and biotechnology2026
Eucalyptus lignin production coupled with Cellic ® CTec3 HS enzymatic hydrolysis to monosaccharides.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this work was to design, develop, and optimise a two-step process for extracting lignin from Eucalyptus globulus residues and subsequently converting the remaining holocellulose into monosaccharides, primarily glucose and xylose. Firstly, the solubility of high-quality lignin was optimised using a new hydro-organo-thermal method involving a diluted imidazole solution in water instead of pure imidazole. Subsequently, enzymatic hydrolysis of the polysaccharides-rich pretreated solid was optimised to give glucose and xylose by using the commercial enzymatic mixture Cellic® CTec3 HS (Novozymes, Bagsværd, Denmark) supplemented with endo-1,4-β-xylanase from Trichoderma viride (Merck, Darmstadt, Germany). The extraction process was thoroughly optimised by acting on several parameters, such as the imidazole concentration, temperature, reaction time, and solid-to-liquid ratio. Under the optimised reaction conditions (imidazole 35 wt%, biomass loading 10 wt%, 120 °C, 2 h, 400 rpm) over the entire process, about 70 wt% of lignin removal was achieved, together with glucose and xylose yields of 99 and 92 mol%, respectively, reaching a high total sugar concentration of 91 g/L in the hydrolysate. KEY POINTS: • A new hydro-organo-thermal treatment of lignocellulosic biomass has been proposed. • Glucose and xylose yields were 99 and 92 mol% in 48 h at low enzyme dosage. • A total reducing sugar concentration of 91 g/L was achieved in the hydrolysate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.